한빛사논문
Minjong Lee 1, Byunghwa Kang 1, Juhwa Lee 2, Jisun Lee 3 4, Sang Taek Jung 3 4, Chang Yun Son 2 5, Seung Soo Oh 1 5*
1Department of Materials Science and Engineering, Pohang University of Science and Technology (POSTECH), Pohang 37673, South Korea.
2Department of Chemistry, Pohang University of Science and Technology (POSTECH), Pohang 37673, South Korea.
3Department of Biomedical Sciences, Graduate School, Korea University, Seoul 02841, South Korea.
4BK21 Graduate Program, Department of Biomedical Sciences, Korea University College of Medicine, Seoul 02841, South Korea.
5Institute for Convergence Research and Education in Advanced Technology (I-CREATE), Yonsei University, Incheon 21983, South Korea.
*Corresponding author : Seung Soo Oh
Abstract
The frequent occurrence of viral variants is a critical problem in developing antiviral prophylaxis and therapy; along with stronger recognition of host cell receptors, the variants evade the immune system-based vaccines and neutralizing agents more easily. In this work, we focus on enhanced receptor binding of viral variants and demonstrate generation of receptor-mimicking synthetic reagents, capable of strongly interacting with viruses and their variants. The hotspot interaction of viruses with receptor-derived short peptides is maximized by aptamer-like scaffolds, the compact and stable architectures of which can be in vitro selected from a myriad of the hotspot peptide-coupled random nucleic acids. We successfully created the human angiotensin-converting enzyme 2 (hACE2) receptor-mimicking hybrid ligand that recruits the hACE2-derived receptor binding domain-interacting peptide to directly interact with a binding hotspot of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Experiencing affinity boosting by ~500% to Omicron, the de novo selected hACE2 mimic exhibited a great binding tolerance to all SARS-CoV-2 variants of concern.
논문정보
관련 링크
연구자 키워드
관련분야 연구자보기
관련분야 논문보기
해당논문 저자보기